We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About SpinaFX Medical Stock

Invest in or calculate the value of your shares in SpinaFX Medical or other pre-IPO companies through EquityZen's platform.

Get Started

SpinaFX Medical Stock (SPFM)

SpinaFX is a medical device company bringing innovative, minimally invasive image-guided treatments to patients.

About SpinaFX Medical Stock

Founded

2021

Industries

Health Care

SpinaFX is a medical device company bringing innovative, minimally invasive image-guided treatments to patients with back pain due to herniated discs. Our patented technology provides surgeons an earlier alternative to conventional surgery, using a minimally invasive technique to deliver a controlled Oxygen formulation to the affected disc, safely reducing the herniation and inflammation causing pain. SpinaFX's Triojection™ product was previously CE Marked under MDD and is undergoing re-certification under MDR. Triojection is not yet approved for sale in the North America, the UK or the EU.

SpinaFX Medical Press Mentions

Stay in the know about the latest news on SpinaFX Medical

SpinaFX Medical Management

Leadership team at SpinaFX Medical

Chief Operating Officer

John Soloninka

Chief Executive Officer

Jeff Cambra

Locked Features

Join now and verify your accreditation status to gain access to:

  • SpinaFX Medical Current Valuation
  • SpinaFX Medical Stock Price
  • SpinaFX Medical Management
  • Available deals in SpinaFX Medical and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • SpinaFX Medical Cap Table and Funding History by Share Class and Liquidity Preferences
    • SpinaFX Medical Revenue and Financials
    • SpinaFX Medical Highlights
    • SpinaFX Medical Business Model
    • SpinaFX Medical Risk Factors
  • SpinaFX Medical Research Report from SACRA Research
Join Now

Trading SpinaFX Medical Stock

How to invest in SpinaFX Medical stock?

Accredited investors can buy pre-IPO stock in companies like SpinaFX Medical through EquityZen funds. These investments are made available by existing SpinaFX Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell SpinaFX Medical stock?

Shareholders can sell their SpinaFX Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."